Search
Technetium Tc-99m etidronate
go.drugbank.com/drugs/DB09411ApprovedCategories: Compounds used in a research, industrial, or household settingChlorine
go.drugbank.com/drugs/DB11109ApprovedInvestigationalChlorine is a stongly oxidizing agent and the third most electronegative element which belongs to the group of halogens with the atomic number 17 and symbol Cl. Being a yellow-green gas at room temperature, chlorine is the second most ab...
Categories: Compounds used in a research, industrial, or household settingD-Cysteine
go.drugbank.com/drugs/DB03201ExperimentalA thiol-containing non-essential amino acid that is oxidized to form CYSTINE.
Ladostigil
go.drugbank.com/drugs/DB16213InvestigationalLadostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment).
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesEB05
go.drugbank.com/drugs/DB16477InvestigationalEB05, in combination with standard of care (SOC), is being investigated in clinical trial NCT04401475 to evaluate its safety and efficacy in adult hospitalized patients with COVID-19 and ARDS.
Categories: Experimental Unapproved Treatments for COVID-19Upanovimab
go.drugbank.com/drugs/DB16505InvestigationalUpanovimab (SCTA01) was under investigation in clinical trials (NCT04683328, NCT04644185, NCT04709328 and NCT05156645) to evaluate its safety and efficacy in patients with severe COVID-19
Categories: Experimental Unapproved Treatments for COVID-19Kojic acid
go.drugbank.com/drugs/DB01759ApprovedCategories: Compounds used in a research, industrial, or household settingDihexyverine
go.drugbank.com/drugs/DB13678ExperimentalCategories: Drugs for Functional Gastrointestinal DisordersVA-MENGOC-BC®
go.drugbank.com/drugs/DB15800ExperimentalAs of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … As there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C.
SYNB1353
go.drugbank.com/drugs/DB17666Investigational[A258833] Developed by Synlogic Operating Company, Inc., SYNB1353 is being investigated for the treatment of homocystinuria.